Call for proposals - Biomarkers
The Medical Research Council, as part of its initiative to target bottlenecks in translation, aims to commit up to £10 million in a call for proposals for the development and evaluation of biomarkers. This MRC led initiative is a key part of the MRC-NIHR strategies for health research.
In this call, the MRC invites applications to further develop potential biomarkers and/or to evaluate potential biomarkers for their predictive and prognostic capability for the diagnosis of disease, disease heterogeneity and underlying mechanisms, susceptibility, exposure or response to interventions. Studies that evaluate biomarkers as markers of either pharmacological activity or efficacy in pre-clinical development will also be considered, as will those proposing the further qualification of safety biomarkers to support early clinical trials.
The primary objective should be to select, evaluate and qualify a biomarker (or discrete panel of biomarkers) as an indicator of a normal biological process, pathogenic process, or pharmacologic response to therapeutic intervention. Any suitable technology approach will be considered.
The deadline for receipt of applications is 4pm, Tuesday 17th June 2008.
For further information on this call, please see the ‘Call for Proposals’ section of the website.
